Shanghai Pharmaceuticals (601607.SH): Amoxicillin Sodium for Injection has passed the consistency evaluation of generic drugs.

Zhixin Finance APP News, Shanghai Pharmaceuticals (601607.SH) announced that recently, its subsidiary Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd. (referred to as "Xinyi Jinzhu") received the "Drug Supplement Application Approval Notice" (Notice No.: 2025B03210) issued by the National Medical Products Administration (referred to as the "NMPA") for its Ammonium Methacrylate Injection. This drug has passed the evaluation of generic drug quality and efficacy consistency.